Cargando…

Toward a Treatment Normalizing Ovulation Rate in Adolescent Girls With Polycystic Ovary Syndrome

Adolescent polycystic ovary syndrome (PCOS) is characterized by androgen excess and oligomenorrhea, and commonly driven by hepato-visceral fat excess (“central obesity”) ensuing from a mismatch between prenatal and postnatal nutrition, on a background of genetic susceptibility. There is no approved...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ibáñez, Lourdes, Díaz, Marta, García-Beltrán, Cristina, Malpique, Rita, Garde, Edurne, López-Bermejo, Abel, de Zegher, Francis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182125/ https://www.ncbi.nlm.nih.gov/pubmed/32342022 http://dx.doi.org/10.1210/jendso/bvaa032

Ejemplares similares

Reduced circulating levels of chemokine CXCL14 in adolescent girls with polycystic ovary syndrome: normalization after insulin sensitization
por: García-Beltran, Cristina, et al.
Publicado: (2020)

OR25-3 Toward a Circulating Marker of Hepato-Visceral Fat Excess: S100A4 in Adolescent Girls with Polycystic Ovary Syndrome
por: Ibanez, Lourdes, et al.
Publicado: (2019)

MON-029 Polycystic Ovary Syndrome (PCOS) in Adolescent Girls:Toward a Simple On-Treatment Predictor of Post-Treatment Ovulation Rate
por: Ibanez, Lourdes, et al.
Publicado: (2020)

Low-Dose Spironolactone-Pioglitazone-Metformin Normalizes Circulating Fetuin-A Concentrations in Adolescent Girls with Polycystic Ovary Syndrome
por: Díaz, Marta, et al.
Publicado: (2018)

FRI426 Raised Thyroid Stimulating Hormone In Girls With Polycystic Ovary SyndromeEffects Of Randomized Interventions
por: Ibanez, Lourdes, et al.
Publicado: (2023)

Differential DNA methylation profile in infants born small-for-gestational-age: association with markers of adiposity and insulin resistance from birth to age 24 months
por: Diaz, Marta, et al.
Publicado: (2020)

Correction to “Toward a Treatment Normalizing Ovulation Rate in Adolescent Girls With Polycystic Ovary Syndrome”
Publicado: (2023)

Effects of half-dose spiomet treatment in girls with early puberty and accelerated bone maturation: a multicenter, randomized, placebo-controlled study protocol
por: Bassols, Judit, et al.
Publicado: (2023)

Correction: Effects of half-dose spiomet treatment in girls with early puberty and accelerated bone maturation: a multicenter, randomized, placebo-controlled study protocol
por: Bassols, Judit, et al.
Publicado: (2023)

A Single Nucleotide Polymorphism in STK11 Influences Insulin Sensitivity and Metformin Efficacy in Hyperinsulinemic Girls With Androgen Excess
por: López-Bermejo, Abel, et al.
Publicado: (2010)

The relative deficit of GDF15 in adolescent girls with PCOS can be changed into an abundance that reduces liver fat
por: de Zegher, Francis, et al.
Publicado: (2021)

Author Correction: The relative deficit of GDF15 in adolescent girls with PCOS can be changed into an abundance that reduces liver fat
por: de Zegher, Francis, et al.
Publicado: (2021)

The significance of anthropometric and endocrine parameters in ovulation induction with clomiphene citrate in women with polycystic ovary syndrome
por: Akpinar, Funda, et al.
Publicado: (2016)

SPIOMET4HEALTH—efficacy, tolerability and safety of lifestyle intervention plus a fixed dose combination of spironolactone, pioglitazone and metformin (SPIOMET) for adolescent girls and young women with polycystic ovary syndrome: study protocol for a multicentre, randomised, double-blind, placebo-controlled, four-arm, parallel-group, phase II clinical trial
por: Garcia-Beltran, Cristina, et al.
Publicado: (2023)

Ovulation induction techniques in women with polycystic ovary syndrome
por: Vyrides, Andreas A., et al.
Publicado: (2022)

On the rising incidence of early breast development: puberty as an adaptive escape from ectopic adiposity in mismatch girls
por: de Zegher, Francis, et al.
Publicado: (2021)

Polycystic Ovary Syndrome: Effect and Mechanisms of Acupuncture for Ovulation Induction
por: Johansson, Julia, et al.
Publicado: (2013)

ODP426 SPIOMET4HEALTH: a 4-Arm Trial to Test the Effects of Lifestyle Intervention plus either Placebo, or Pioglitazone (PIO), or Spironolactone-Pioglitazone (SPIO), or Spironolactone-Pioglitazone-Metformin (SPIOMET) in Adolescent Girls and Young Women with PCOS
por: Ibanez, Lourdes, et al.
Publicado: (2022)

Body Composition and Circulating High-Molecular-Weight Adiponectin and IGF-I in Infants Born Small for Gestational Age : Breast- Versus Formula-Feeding
por: de Zegher, Francis, et al.
Publicado: (2012)

Letrozole is superior to clomiphene citrate in ovulation induction in patients with polycystic ovary syndrome
por: Sakar, Mehmet Nafi, et al.
Publicado: (2020)

Oxidative stress and antioxidant imbalance in ovulation disorder in patients with polycystic ovary syndrome
por: Li, Wenqian, et al.
Publicado: (2022)

Predictors of response to ovulation induction using letrozole in women with polycystic ovary syndrome
por: Guo, Zaixin, et al.
Publicado: (2023)

The Circadian Variation in Anti-Müllerian Hormone in Patients with Polycystic Ovary Syndrome Differs Significantly from Normally Ovulating Women
por: Bungum, Leif, et al.
Publicado: (2013)

The inositols and polycystic ovary syndrome
por: Kalra, Bharti, et al.
Publicado: (2016)

Circulating exosomes decrease in size and increase in number between birth and age 7: relations to fetal growth and liver fat
por: Díaz, Marta, et al.
Publicado: (2023)

Ovulation in the Human Ovary
por: Shaw, Wilfred
Publicado: (1928)

Meteorin-like levels are associated with active brown adipose tissue in early infancy
por: Garcia-Beltran, Cristina, et al.
Publicado: (2023)

Higher levels of serum α-Klotho are longitudinally associated with less central obesity in girls experiencing weight gain
por: Carreras-Badosa, Gemma, et al.
Publicado: (2023)

Unilateral or bilateral vagotomy induces ovulation in both ovaries of rats with polycystic ovarian syndrome
por: Linares, Rosa, et al.
Publicado: (2013)

N-Acetylcysteine as an Adjuvant to Letrozole for Induction of Ovulation in Infertile Patients with Polycystic Ovary Syndrome
por: Mostajeran, Fateme, et al.
Publicado: (2018)

Role of luteinizing hormone elevation in outcomes of ovulation induction with letrozole for polycystic ovary syndrome
por: Fu, Wenyan, et al.
Publicado: (2023)

Persisting benefits 12–18 months after discontinuation of pubertal metformin therapy in low birthweight girls
por: Ong, Ken, et al.
Publicado: (2007)

Abundance of Circulating Preadipocyte Factor 1 in Early Life
por: de Zegher, Francis, et al.
Publicado: (2012)

Ovulation induction by metformin among obese versus non-obese women with polycystic ovary syndrome
por: Al-Ruthia, Yazed Sulaiman, et al.
Publicado: (2017)

Ovulation stigma and rupture of ovarian tunica albuginea in a patient with polycystic ovary syndrome (video)
por: Alhalabi, Nawras, et al.
Publicado: (2021)

Bone morphogenetic proteins and the polycystic ovary syndrome
por: van Houten, E Leonie AF, et al.
Publicado: (2013)

Predictive factors of polycystic ovary syndrome in girls with precocious pubarche
por: Guarnotta, Valentina, et al.
Publicado: (2021)

Unilateral sectioning of the superior ovarian nerve of rats with polycystic ovarian syndrome restores ovulation in the innervated ovary
por: Morales-Ledesma, Leticia, et al.
Publicado: (2010)

The impact of hyperandrogenism on the outcomes of ovulation induction using gonadotropin and intrauterine insemination in women with polycystic ovary syndrome
por: Ho, Vu Ngoc Anh, et al.
Publicado: (2022)

The Effect of Insulin Resistance on Ovulation Induction With Clomiphene Citrate in Non-polycystic Ovary Syndrome (PCOS) Women
por: Karnatak, Ruchi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_frtk8859u9p03q8iumegbtnrdr